Plasmodium falciparum-specific interleukin-2 and tumor necrosis factor-α expressing-T cells are associated with resistance to reinfection and severe malaria in healthy African children

European Cytokine Network

Volumn 15, Issue 3, 2004, Pages 189-196

  Ramharter, Michael ^a,b,c   Kremsner, Peter G ^b,c   Willheim, Martin ^d   Winkler, Heidi ^a,c   Graninger, Wolfgang ^a   Winkler, Stefan ^a,c  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c Med Res U Albert Schweitzer Hosp   (Gabon)

^d UNIVERSITY OF VIENNA   (Austria)

Author keywords

Cytokines; Plasmodium falciparum malaria; T cells

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CD94 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR DELTA CHAIN; T LYMPHOCYTE RECEPTOR GAMMA CHAIN; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; AFRICA; ARTICLE; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; FLOW CYTOMETRY; GABON; HUMAN; HUMAN CELL; LONGITUDINAL STUDY; MALARIA; MALE; PLASMODIUM FALCIPARUM; PROTEIN EXPRESSION; REINFECTION; SCHOOL CHILD; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

ADOLESCENT; AFRICA; ANIMALS; BASE SEQUENCE; CHILD; COHORT STUDIES; DNA PRIMERS; FEMALE; FLOW CYTOMETRY; HUMANS; INTERLEUKIN-2; LONGITUDINAL STUDIES; MALARIA, FALCIPARUM; MALE; PLASMODIUM FALCIPARUM; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

PLASMODIUM FALCIPARUM;

EID: 6344238534     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Snow RW, Craig M, Deichmann U, Marsh K. 1999. Estimating mortality, morbidity and disability due to malaria among Africa's non-pregnant population. Bull World Health Org. 77: 624.
2. Sylla EH, Kun JF, Kremsner PG. 2000. Mosquito distribution and entomological inoculation rates in three malaria-endemic areas in Gabon. Trans R Soc Trop Med Hyg. 94: 652.
3. Wildling E, Winkler S, Kremsner PG, Brandts C, Jenne L, Wernsdorfer WH. 1995. Malaria epidemiology in the province of Moyen Ogooué, Gabon Trop Med Parasitol. 46: 77.
4. Miller LH, Baruch DI, Marsh K, Doumbo OK. 2002. The pathogenic basis of malaria. Nature. 415: 673.
5. Troye-Blomberg M, Berzins K, Perlmann P. 1994. T-cell control of immunity to the asexual stages of the malaria parasite. Crit Rev Immunol. 14: 131.
6. Grau GE, Taylor TE, Molyneux ME, Wirima JJ, Vassalli P, Hommel M, Lambert PH. 1989. Tumor necrosis factor and disease severity in children with falciparum malaria. N Engl J Med. 320: 1586.
7. Kwiatkowski D, Hill AV, Sambou I, Twumasi P, Castracane J, Manogue KR, Cerami A, Brewster DR, Greenwood BM. 1990. TNF concentrations in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet. 336: 1201.
8. Kwiatkowski D, Molyneux ME, Stephens S, Curtis N, Klein N, Pointaire P, Smit M, Allan R, Brewster DR, Grau GE. 1993. Anti-TNF therapy inhibits fever in cerebral malaria. Q J Med. 86: 91.
9. Day NPJ, Tinh Hien T, Schollaardt T, Loc PP, Chuong LV, Chau TT, Mai NT, Phu NH, Sinh DX, White NJ, Ho M. 1999. The prognostic and pathophysiologic role of pro- and anti-inflammatory cytokines in severe malaria. J Infect Dis. 180: 1288.
10. Kurtzhals JAL, Adabayeri V, Goka BQ, Akanmori BD, Oliver-Commey JO, Nkrumah FK, Behr C, Hviid L. 1998. Low plasma concentrations of interleukin 10 in severe malarial anaemia compared with cerebral and uncomplicated malaria. Lancet. 351: 1768.
11. Othoro C, Lal AA, Nahlen B, Koech D, Orago AS, Udhayakumar V. 1999. A low interleukin-10 tumor necrosis factor-α ratio is associated with malaria anemia in children residing in a holoendemic malaria region in western Kenya. J Infect Dis. 179: 279.
12. Harpaz R, Edelman R, Wasserman SS, Levine MM, Davies JR, Sztein MB. 1992. Serum cytokine profiles in experimental human malaria. J Clin Invest. 90: 515.
13. + T cells reactive with Plasmodium chcibandi chabaudi: distinct response kinetics for cells with Th1 and Th2 characteristics during infection. Int Immunol. 1: 416.
14. Stevenson MM, Tam MF. 1993. Differential induction of helper T cell subsets during blood-stage Plasmodium chabaudi AS infection in resistant and susceptible mice. Clin Exp Immunol. 92: 77.
15. Stevenson MM, Tam MF, Wolf SF, Sher A. 1995. IL-12 induced protection against blood-stage Plasmodium chabaudi AS requires IFN-γ and TNF-α and occurs via a nitric oxide dependent mechanism. J Immunol. 155: 2545.
16. Perlman H, Kumar S, Vinetz JM, Kullberg M, Miller LH, Perlmann P. 1995. Cellular mechanisms in the immune response to malaria in Plasmodium vinckei infected mice. Infect Immun. 63: 3987.
17. Jacobs P, Radzioch D, Stevenson MM. 1996. In vivo regulation of nitric oxide production by tumor necrosis factor alpha and gamma Interferon, but not by interleukin-4, during blood stage malaria in mice. Infect Immun. 64: 44.
18. Jacobs P, Radzioch D, Stevenson MM. 1996. A Th1-associated increase in tumor necrosis factor alpha expression in the spleen correlates with resistance to blood-stage malaria in mice. Infect Immun. 64: 535.
19. Mohan K, Moulin P, Stevenson MM. 1997. Natural killer cell cytokine production, not cytotoxicity, contributes to resistance against blood-stage Plasmodium chabaudi AS infection. J Immunol. 159: 4990.
20. Kremsner PG, Neifer S, Schermuck S, Ferreira Chaves M, Sliwa K, Bienzle U. 1991. Interferon-γ enhances the effect of antimalarial chemotherapy in murine Plasmodium vinckei malaria. J Infect Dis. 163: 1161.
21. Kremsner PG, Winkler S, Brandts C, Wildling E, Jenne L, Graninger W, Prada J, Bienzle U, Juillard P, Grau GE. 1995. Prediction of accelerated cure in Plasmodium falciparum malaria by the elevated capacity of tumor necrosis factor production. Am J Trop Med Hyg. 53: 532.
22. Mordmüller BG, Metzger WG, Juillard P, Brinkman BM, Verweij CL, Grau GE, Kremsner PG. 1997. Tumor necrosis factor in Plasmodium falciparum malaria: high plasma level is associated with fever, but high production capacity is associated with rapid fever clearance. Eur Cytokine Netw. 8: 29.
23. Luty AJ, Lell B, Schmidt-Ott R, Lehman LG, Luckner D, Greve B, Matousek P, Herbich K, Schmid D, Migot-Nabias F, Deloron P, Nussenzweig RS, Kremsner PG. 1999. Interferon-γ responses are associated with resistance to reinfection with Plasmodium falciparum in young African children. J Infect Dis. 179: 980.
24. Kurtis JD, Lanar DE, Opollo M, Duffy PE. 1999. Interleukin-10 responses to liver-stage antigen 1 predict human resistance to Plasmodium falciparum. Infect Immun. 67: 3424.
25. Kun JF, Schmidt-Ott RJ, Lehman LG, Lell B, Luckner D, Greve B, Matousek P, Kremsner PG. 1998. Merozoite surface antigen 1 and 2 genotypes and rosetting of Plasmodium falciparum in severe and mild malaria in Lambaréné, Gabon. Trans R Soc Trop Med Hyg. 92: 110.
26. Van Kuppeveld FJ, van der Logt JT, Angulo AF, van Zoest MJ, Quint WG, Niesters HG, Galama JM, Melchers WJ. 1992. Genus- and species-specific identification of mycoplasmas by 16S rRNA amplification. Appl Environ Microbiol. 58: 2606.
27. Staalsoe T, Giha HA, Dodoo D, Theander TG, Hviid L. 1999. Detection of antibodies to variant antigens on Plasinodium falciparum-infected erythrocytes by flow cytometry. Cytometry. 35: 329.
28. Hensmann M, Kwiatkowski D. 2001. Cellular basis of early cytokine response to Plasmodium falciparum Infect Immun. 69: 2364.
29. Ramharter M, Willheim M, Winkler H, Wahl K, Lagler H, Graninger W, Winkler S. 2003. Cytokine profile of Plasmodium falciparum-specific T cells in non-immune malaria patients. Parasite Immunol. 25: 211.
30. Suni MA, Picker LJ, Maino VC. 1998. Detection of antigen-specific cytokine expression in whole blood by flow cytometry. J Immunol Methods. 212: 89.
31. Winkler S, Willheim M, Baier K, Schmid D, Aichelburg A, Graninger W, Kremsner PG. 1998. Reciprocal regulation of Th1- and Th2-cytokine-producing T cells during clearance of parasitemia in Plasmodium falciparum malaria. Infect Immun. 66: 6040.
32. Winkler S, Willheim M, Baier K, Schmid D, Aichelburg A, Graninger W, Kremsner PG. 1999. Frequency of cytokine-producing T cells in patients of different age groups with Plasmodium falciparum malaria. J Infect Dis. 179: 209.
33. Hviid L, Kurtzhals JA, Goka BQ, Oliver-Commey JO, Nkrumah FK, Theander TG. 1997. Rapid reemergence of T cells into peripheral circulation following treatment of severe and uncomplicated Plasmodium falciparum malaria. Infect Immun. 65: 4090.
34. Kemp K, Akanmori BD, Adabayeri V, Goka BQ, Kurtzhals JA, Behr C, Hviid L. 2002. Cytokine production and apoptosis among T cells from patients under treatment for Plasmodium falciparum malaria. Clin Exp Immunol. 127: 151.
35. Luckner D, Lell B, Greve B, Lehman LG, Schmidt-Ott RJ, Matousek P, Herbich K, Schmid D, Mba R, Kremsner PG. 1998. No influence of socioeconomic factors on severe malarial anemia, hyperparasitemia or reinfection. Trans R Soc Trop Med Hyg. 92: 478.
36. Smith KA. 1988. Interleukin-2: inception, impact, and implications. Science. 240: 1169.
37. Troye-Blomberg M, Andersson G, Stoczkowska M, Shabo R, Romero P, Patarroyo ME, Wigzell H, Perlmann P. 1985. Production of IL-2 and interferon-gamma by T cells from malaria patients in response to Plasmodium falciparum or erythrocyte antigens in vitro. J Immunol. 135: 3498.
38. Ho M, Webster HK, Green B, Looareesuwan S, Kongchareon S, White NJ. 1988. Defective production of and response to IL-2 in acute human falciparum malaria. J Immunol. 141: 2755.
39. Kremsner PG, Zotter GM, Feldmeier H, Graninger W, Rocha RM, Jansen-Rosseck R, Bienzle U. 1990. Immune response in patients during and after Plasmodium falciparum infection. J Infect Dis. 161: 1025.
40. + T cells and the recognition of MHC class I molecules. Immunology. 89: 405.
41. Elloso MM, Wallace M, Manning DD, Weidanz WP. 1998. The effects of interleukin-15 on human γδ T cell responses to Plasmodium falciparum in vitro. Immunol Lett. 64: 125.
42. + T cells preferentially respond to live rather than killed malaria parasites. Infect Immun. 66: 2393.
43. Haque A, Echchannaoui H, Seguin R, Schwartzman J, Kasper LH, Haque S. 2001. Cerebral malaria in mice: interleukin-2 treatment induces accumulation of γδ T cells in the brain and alters resistant mice to susceptible-like phenotype. Am J Pathol. 158: 163.
44. Scragg IG, Hensmann M, Bate CA, Kwiatkowski D. 1999. Early cytokine induction by Plasmodium falciparum is not a classical endotoxin-like process. Eur J Immunol. 29: 2636.
45. May J, Lell B, Luty AJ, Meyer CG, Kremsner PG. 2000. Plasma interleukin-10: Tumor necrosis factor (TNF)-α ratio is associated with TNF promoter variants and predicts malarial complications. J Infect Dis. 182: 1570.
46. Perkins DJ, Kremsner PG, Schmid D, Misukonis MA, Kelly MA, Weinberg JB. 1999. Blood mononuclear cell nitric oxide production and plasma cytokine levels in healthy Gabonese children with prior mild or severe malaria. Infect Immun. 67: 4977.
47. Trinchieri G. 2001. Regulatory role of T cells producing both interferon γ and interleukin 10 in persistent infection. J Exp Med. 194: F53.
48. Zevering Y, Amante F, Smillie A, Currier J, Smith G, Houghten RA, Good MF. 1992. High frequency of malaria-specific T cells in non-exposed humans. Eur J Immunol. 22: 689.